Wendall Wierenga Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

Wendall Wierenga is of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 116,146 shares of CRNX, which is worth approximately $3.24 Million. The most recent transaction as insider was on Jun 11, 2025, when has been sold 6,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K

6.32% 3M change

6.32% 12M change

Total Value Held $3.24 Million

WENDALL WIERENGA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2025	BUY Grant, award, or other acquisition	-	6,900 Added 5.61%	116,146 Common Stock
Jun 07 2024	BUY Grant, award, or other acquisition	-	3,400 Added 3.02%	109,246 Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	6,000 Added 5.36%	105,846 Common Stock
Apr 28 2020	BUY Exercise of conversion of derivative security	$18,490 $0.73 p/Share	25,329 Added 20.23%	99,846 Common Stock

Also insider at

CYTK

CYTOKINETICS INC Healthcare

Director